Evaluation of sixteen ELISA SARS-CoV-2 serological tests

BACKGROUND: In response to the current COVID-19 pandemic, multiple companies marketed serological tests. Rigorous, independent and comparative performances of these assays on defined clinical specimens are needed. METHODS: In a first preliminary phase, we investigated 16 IgG, IgM, IgA and pan Ig ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacot, Damien, Moraz, Milo, Coste, Alix T., Aubry, Christele, Sacks, Jilian A., Greub, Gilbert, Croxatto, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295192/
https://www.ncbi.nlm.nih.gov/pubmed/34365228
http://dx.doi.org/10.1016/j.jcv.2021.104931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295192/
https://www.ncbi.nlm.nih.gov/pubmed/34365228
http://dx.doi.org/10.1016/j.jcv.2021.104931

Ejemplares similares